Clin2
NCT07086911Possibly a fitNot yet recruiting

Study of Remimazolam for Lung Surgery in Older Adults

Remimazolam BesylateThoracoscopic LobectomyOxygenationPostoperative Cognitive Dysfunction

Treatments studied

Part of Mental health clinical trials.

This study tests whether a newer sedative drug (remimazolam) helps elderly patients breathe better and think more clearly after keyhole lung surgery. It compares this drug to a standard one to see which one leads to better oxygen levels and less confusion after the operation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
150 people
Ages
65 years to 75 years
Study type
Interventional

Who can take part

  • You are scheduled for a thoracoscopic (keyhole) lung surgery.
  • You are between 65 and 75 years old.
  • You have a body mass index (BMI) between 18 and 30.
  • You do not have a very slow heartbeat or heart block.
  • You have not taken certain medications (like for anxiety, seizures, or depression) in the past six months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07113483Recruiting· Phase 3
Remimazolam vs. Midazolam for sedation in older adults having orthopedic surgery

This trial compares two sedatives, remimazolam and midazolam, to see which one leads to better recovery of thinking skills after orthopedic surgery. It is for people aged 65 and older who are having surgery on a bone or joint while awake but relaxed.

Bucharest
NCT07351474Not yet recruiting
Remimazolam to prevent confusion after stomach surgery in seniors

This trial tests if a sedative called remimazolam can reduce confusion or delirium in older adults after laparoscopic stomach surgery. If you are at least 65 years old and scheduled for this surgery, you may be eligible.

Nanjing, Jiangsu
NCT07347496Not yet recruiting· Phase 4
Comparing two anesthesia plans for chest surgery

This trial tests a newer anesthesia drug (remimazolam) combined with alfentanil against a standard drug (propofol) combined with alfentanil for people having chest surgery. The goal is to see which approach works better and is safer.

NCT07395596Recruiting· Phase 4
Remimazolam for Bronchoscopy in High-Risk Patients

This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.

Hangzhou, Zhejiang
NCT06496165Not yet recruiting
Sedation study for heart bypass patients in ICU

This trial compares two types of sedation for older adults recovering from heart bypass surgery in the ICU. It aims to see which drug keeps your heart function more stable while you are on a breathing machine.

Shanghai, Shanghai Municipality
NCT06717945Not yet recruiting· Early Phase 1
Testing remimazolam for heart surgery sedation

This trial tests a new sedative called remimazolam for people having planned heart surgery with a heart-lung machine. It aims to see if it works well and is safe for keeping you asleep during the operation.

Hear when a new Remimazolam Besylate trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.